QA: Avadel Pharmaceuticals PLC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001012477_2022_Avadel_Pharmaceuticals_PLC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001012477, Avadel Pharmaceuticals PLC

  xvar xval
0 AssetsCurrent 192,490,000
1 IntangibleAssetsNetIncludingGoodwill 16,836,000
2 PropertyPlantAndEquipmentNet 285,000
3 remainder_Assets 37,654,000
4 LiabilitiesCurrent 21,000,000
5 LiabilitiesNoncurrent 148,021,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold -5,534,088
8 SellingGeneralAndAdministrativeExpense 93,596,457
9 ResearchAndDevelopmentExpense 15,680,915
10 remainder_Expenses -10,252,179
11 remainder_Revenues -260,637
12 remainder_NetIncome 2,255,535
13 remainder_ComprehensiveNetIncome -1,375,776
  yvar yval
0 Assets 247,265,000
1 Liabilities 169,021,000
2 Expenses 93,491,105
3 Revenues -260,637
4 StockholdersEquity 78,244,000
5 NetIncome -91,496,207
6 ComprehensiveNetIncome -92,184,095
7 BaseVar 256,834,526
8 EconomicCapitalRatiobeforeLimitedLiability 0.377
9 EconomicCapitalRatio 1.77

Edgar->Model Mapping

Feature Distribution

Change over Time